Inflammatory bowel diseases such as Crohn's disease and ulcerative colitis represent aberrant or dysregulated immune responses of the gastrointestinal tract, which lead to a state of chronic inflammation. Recent discoveries have linked the gene encoding for interleukin-23 (IL-23) receptor with the development of Crohn's, and it is believed that IL-23 has a much larger effect on these inflammatory diseases, as well as affecting risk for both Crohn's and colitis. However, how IL-23 initiates intestinal inflammation remains unclear. Recent data have suggested that the pathogenic role of IL-23 is not only associated with its important role in expanding Th17 cells, but also in driving inflammation mediated by non-T cells. This subset of innate cells that responds to IL-23 and mediates colitis was identified both in mice and in humans, as a subset: group 3 innate lymphoid cells (ILC3) that express the transcriptional factor ROR?t. To determine whether the subsets of ILC3s that promote protective immunity infection are the same as the ones that promote colitis, we used mouse strains that lack certain subsets of ILC3s and evaluated their susceptibility to infection and to develop colitis. Our results suggested that the population of ILC3s that promotes protective immunity is absent in mice that lack the transcriptional factor AHR, whereas the subset of ILC3s that initiate colitis does not require AHR for its function or development. To identify which ones of ILCs promote colitis and the mechanisms by which these cells drive intestinal inflammation, we have generated a triple reporter mouse in which ILC3s that express the transcriptional ROR?t, IL-17 and IFN-g can be tracked in vivo. We believe that this novel cytokine reporter mouse will help us better understand the key role of ILC3s in the development of inflammatory diseases. These studies are needed before we can envision targeting these innate cells for therapeutic benefits.

Public Health Relevance

IL-23 and IL-15 are important cytokines involved in IBD. However, the mechanisms by which these cytokines promote mucosal inflammation remain elusive. Our study is aimed at understanding the molecular mechanisms by these two cytokines regulate the function of group 3 ILCs in the GI tract in mice and humans that suffer from IBD.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Rothermel, Annette L
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Seattle Children's Hospital
United States
Zip Code
Oukka, Mohamed; Bettelli, Estelle (2018) Regulation of lymphocyte trafficking in central nervous system autoimmunity. Curr Opin Immunol 55:38-43
Singh, Akhilesh K; Eken, Ahmet; Hagin, David et al. (2017) DOCK8 regulates fitness and function of regulatory T cells through modulation of IL-2 signaling. JCI Insight 2:
Eken, Ahmet; Duhen, Rebekka; Singh, Akhilesh K et al. (2017) S1P1 deletion differentially affects TH17 and Regulatory T cells. Sci Rep 7:12905